Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 3
1950 1
1952 1
1955 1
1958 1
1964 1
1965 1
1966 1
1977 1
1978 1
1979 12
1980 4
1981 4
1982 4
1983 11
1984 10
1985 15
1986 17
1987 28
1988 21
1989 12
1990 12
1991 21
1992 28
1993 27
1994 53
1995 35
1996 54
1997 71
1998 78
1999 65
2000 113
2001 116
2002 162
2003 194
2004 245
2005 318
2006 403
2007 465
2008 512
2009 569
2010 742
2011 932
2012 1136
2013 1548
2014 1993
2015 2310
2016 2325
2017 2711
2018 3017
2019 3585
2020 4127
2021 4633
2022 5299
2023 5417
2024 1682

Text availability

Article attribute

Article type

Publication date

Search Results

40,339 results

Results by year

Filters applied: . Clear all
Page 1
Analysis of status and countermeasures of cancer incidence and mortality in China.
Wu C, Li M, Meng H, Liu Y, Niu W, Zhou Y, Zhao R, Duan Y, Zeng Z, Li X, Li G, Xiong W, Zhou M. Wu C, et al. Among authors: liu y. Sci China Life Sci. 2019 May;62(5):640-647. doi: 10.1007/s11427-018-9461-5. Epub 2019 Mar 12. Sci China Life Sci. 2019. PMID: 30900169 Review.
On September 12, 2018, the academic journal A Cancer Journal for Clinicians published an article about the latest statistics of cancers worldwide, which provided a status report on the global burden of 36 cancers in 185 countries worldwide. ...This review ana …
On September 12, 2018, the academic journal A Cancer Journal for Clinicians published an article about the latest statistics of ca
Critical role of FOXO3a in carcinogenesis.
Liu Y, Ao X, Ding W, Ponnusamy M, Wu W, Hao X, Yu W, Wang Y, Li P, Wang J. Liu Y, et al. Mol Cancer. 2018 Jul 25;17(1):104. doi: 10.1186/s12943-018-0856-3. Mol Cancer. 2018. PMID: 30045773 Free PMC article. Review.
FOXO3a is widely implicated in a variety of diseases, particularly in malignancy of breast, liver, colon, prostate, bladder, and nasopharyngeal cancers. Emerging evidences indicate that FOXO3a acts as a tumor suppressor in cancer. ...The role of FOXO3a in both norma …
FOXO3a is widely implicated in a variety of diseases, particularly in malignancy of breast, liver, colon, prostate, bladder, and nasopharyng …
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.
Donehower LA, Soussi T, Korkut A, Liu Y, Schultz A, Cardenas M, Li X, Babur O, Hsu TK, Lichtarge O, Weinstein JN, Akbani R, Wheeler DA. Donehower LA, et al. Among authors: liu y. Cell Rep. 2019 Jul 30;28(5):1370-1384.e5. doi: 10.1016/j.celrep.2019.07.001. Cell Rep. 2019. PMID: 31365877 Free PMC article.
The TP53 tumor suppressor gene is frequently mutated in human cancers. An analysis of five data platforms in 10,225 patient samples from 32 cancers reported by The Cancer Genome Atlas (TCGA) enables comprehensive assessment of p53 pathway involvement in these …
The TP53 tumor suppressor gene is frequently mutated in human cancers. An analysis of five data platforms in 10,225 patient samples f …
Noncoding RNAs regulate alternative splicing in Cancer.
Liu Y, Liu X, Lin C, Jia X, Zhu H, Song J, Zhang Y. Liu Y, et al. J Exp Clin Cancer Res. 2021 Jan 6;40(1):11. doi: 10.1186/s13046-020-01798-2. J Exp Clin Cancer Res. 2021. PMID: 33407694 Free PMC article. Review.
Defects in AS influence the occurrence and development of many diseases, including cancers, and are frequently found to participate in various aspects of cancer biology, such as promoting invasion, metastasis, apoptosis resistance and drug resistance. ...Consequentl …
Defects in AS influence the occurrence and development of many diseases, including cancers, and are frequently found to participate i …
The emerging role of the piRNA/piwi complex in cancer.
Liu Y, Dou M, Song X, Dong Y, Liu S, Liu H, Tao J, Li W, Yin X, Xu W. Liu Y, et al. Mol Cancer. 2019 Aug 9;18(1):123. doi: 10.1186/s12943-019-1052-9. Mol Cancer. 2019. PMID: 31399034 Free PMC article. Review.
However, the functions of piRNAs in cancer and their underlying mechanisms remain incompletely understood. In this review, we discuss current findings regarding piRNA biogenetic processes, functions, and emerging roles in cancer, providing new insights regarding the …
However, the functions of piRNAs in cancer and their underlying mechanisms remain incompletely understood. In this review, we discuss …
Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy.
Hu X, Wang J, Chu M, Liu Y, Wang ZW, Zhu X. Hu X, et al. Among authors: liu y. Mol Ther. 2021 Mar 3;29(3):908-919. doi: 10.1016/j.ymthe.2020.12.032. Epub 2021 Jan 1. Mol Ther. 2021. PMID: 33388422 Free PMC article. Review.
PD-1/PD-L1 is a major coinhibitory checkpoint pathway that modulates immune escape in cancer patients, and its engagement and inhibition has significantly reshaped the landscape of tumor clearance. ...Moreover, we briefly expound on the anticancer potential of some agents …
PD-1/PD-L1 is a major coinhibitory checkpoint pathway that modulates immune escape in cancer patients, and its engagement and inhibit …
COL1A1: A novel oncogenic gene and therapeutic target in malignancies.
Li X, Sun X, Kan C, Chen B, Qu N, Hou N, Liu Y, Han F. Li X, et al. Among authors: liu y. Pathol Res Pract. 2022 Aug;236:154013. doi: 10.1016/j.prp.2022.154013. Epub 2022 Jul 5. Pathol Res Pract. 2022. PMID: 35816922 Review.
COL1A1 is also associated with cancer progression and prognosis; elevated COL1A1 expression is associated with poor prognosis in cancer patients. However, the main role of COL1A as a cancer-promoting factor in specific tumors has not been reported. ...
COL1A1 is also associated with cancer progression and prognosis; elevated COL1A1 expression is associated with poor prognosis in c
Ferroptosis in life: To be or not to be.
Xu L, Liu Y, Chen X, Zhong H, Wang Y. Xu L, et al. Among authors: liu y. Biomed Pharmacother. 2023 Mar;159:114241. doi: 10.1016/j.biopha.2023.114241. Epub 2023 Jan 10. Biomed Pharmacother. 2023. PMID: 36634587 Free article. Review.
Ferroptosis involves various physiological and pathological processes, and increasing evidence indicates that ferroptosis play a critical role in cancers and other diseases. It inhibits the proliferation of malignant cells in various types of cancers and inducing fe …
Ferroptosis involves various physiological and pathological processes, and increasing evidence indicates that ferroptosis play a critical ro …
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer.
Liu Y , Bhattarai P , Dai Z , Chen X . Liu Y , et al. Chem Soc Rev. 2019 Apr 1;48(7):2053-2108. doi: 10.1039/c8cs00618k. Chem Soc Rev. 2019. PMID: 30259015 Free PMC article. Review.
Second, we introduce the advantages of combining PTT with other therapies in cancer treatment. Third, the emerging applications of PAI in cancer-related research are exemplified. ...We believe that PTT and PAI having noteworthy features would become promising next-g …
Second, we introduce the advantages of combining PTT with other therapies in cancer treatment. Third, the emerging applications of PA …
Landscape of somatic alterations in large-scale solid tumors from an Asian population.
Wu L, Yao H, Chen H, Wang A, Guo K, Gou W, Yu Y, Li X, Yao M, Yuan S, Pang F, Hu J, Chen L, Liu W, Yao J, Zhang S, Dong X, Wang W, Hu J, Ling Q, Ding S, Wei Y, Li Q, Cao W, Wang S, Di Y, Feng F, Zhao G, Zhang J, Huang L, Xu J, Yan W, Tong Z, Jiang D, Ji T, Li Q, Xu L, He H, Shang L, Liu J, Wang K, Wu D, Shen J, Liu Y, Zhang T, Liang C, Wang Y, Shang Y, Guo J, Liang G, Xu S, Liu J, Wang K, Wang M. Wu L, et al. Among authors: liu y. Nat Commun. 2022 Jul 23;13(1):4264. doi: 10.1038/s41467-022-31780-9. Nat Commun. 2022. PMID: 35871175 Free PMC article.
Extending the benefits of tumor molecular profiling for all cancer patients requires a comprehensive analysis of tumor genomes across distinct patient populations worldwide. ...We perform a comprehensive comparison of somatically altered genes, the distribution of tumor mu …
Extending the benefits of tumor molecular profiling for all cancer patients requires a comprehensive analysis of tumor genomes across …
40,339 results
You have reached the last available page of results. Please see the User Guide for more information.